238 related articles for article (PubMed ID: 27916409)
41. Viraemia and clinical disease in Dorset Poll sheep following vaccination with live attenuated bluetongue virus vaccines serotypes 16 and 4.
Veronesi E; Darpel KE; Hamblin C; Carpenter S; Takamatsu HH; Anthony SJ; Elliott H; Mertens PP; Mellor PS
Vaccine; 2010 Feb; 28(5):1397-403. PubMed ID: 19895921
[TBL] [Abstract][Full Text] [Related]
42. Evaluation of cross-protection of bluetongue virus serotype 4 with other serotypes in sheep.
Zulu GB; Venter EH
J S Afr Vet Assoc; 2014 Oct; 85(1):1041. PubMed ID: 25686101
[TBL] [Abstract][Full Text] [Related]
43. Risk factors associated with the occurrence of undesired effects in sheep and goats after field vaccination with modified-live vaccine against bluetongue virus serotypes 2, 4 and 16.
Savini G; Cannas A; Casaccia C; Di Gialleonardo L; Leone A; Patta C; Nicolussi P
Vet Microbiol; 2010 Nov; 146(1-2):44-50. PubMed ID: 20537822
[TBL] [Abstract][Full Text] [Related]
44. Clinical disease in sheep caused by bluetongue virus serotype 8, and prevention by an inactivated vaccine.
Moulin V; Noordegraaf CV; Makoschey B; van der Sluijs M; Veronesi E; Darpel K; Mertens PP; de Smit H
Vaccine; 2012 Mar; 30(12):2228-35. PubMed ID: 22207091
[TBL] [Abstract][Full Text] [Related]
45. Expression of VP7, a Bluetongue virus group specific antigen by viral vectors: analysis of the induced immune responses and evaluation of protective potential in sheep.
Bouet-Cararo C; Contreras V; Caruso A; Top S; Szelechowski M; Bergeron C; Viarouge C; Desprat A; Relmy A; Guibert JM; Dubois E; Thiery R; Bréard E; Bertagnoli S; Richardson J; Foucras G; Meyer G; Schwartz-Cornil I; Zientara S; Klonjkowski B
PLoS One; 2014; 9(11):e111605. PubMed ID: 25364822
[TBL] [Abstract][Full Text] [Related]
46. VP2, VP7, and NS1 proteins of bluetongue virus targeted in avian reovirus muNS-Mi microspheres elicit a protective immune response in IFNAR(-/-) mice.
Marín-López A; Otero-Romero I; de la Poza F; Menaya-Vargas R; Calvo-Pinilla E; Benavente J; Martínez-Costas JM; Ortego J
Antiviral Res; 2014 Oct; 110():42-51. PubMed ID: 25057758
[TBL] [Abstract][Full Text] [Related]
47. Evaluation of humoral response and protective efficacy of two inactivated vaccines against bluetongue virus after vaccination of goats.
Bréard E; Belbis G; Hamers C; Moulin V; Lilin T; Moreau F; Millemann Y; Montange C; Sailleau C; Durand B; Desprat A; Viarouge C; Hoffmann B; de Smit H; Goutebroze S; Hudelet P; Zientara S
Vaccine; 2011 Mar; 29(13):2495-502. PubMed ID: 21256877
[TBL] [Abstract][Full Text] [Related]
48. Laboratory evaluation of a living attenuated vaccine against bluetongue type 20 virus.
Wark MC; Shepherd-Clark MB; Smith HV; Collins WD
Aust Vet J; 1982 Jul; 59(1):6-10. PubMed ID: 6293439
[TBL] [Abstract][Full Text] [Related]
49. Evaluation of adaptive immune responses and heterologous protection induced by inactivated bluetongue virus vaccines.
Breard E; Belbis G; Viarouge C; Nomikou K; Haegeman A; De Clercq K; Hudelet P; Hamers C; Moreau F; Lilin T; Durand B; Mertens P; Vitour D; Sailleau C; Zientara S
Vaccine; 2015 Jan; 33(4):512-8. PubMed ID: 25500308
[TBL] [Abstract][Full Text] [Related]
50. Presence of Antibodies against Bluetongue Virus (BTV) in Sheep 5 to 7.5 Years after Vaccination with Inactivated BTV-8 Vaccines.
Hilke J; Strobel H; Woelke S; Stoeter M; Voigt K; Moeller B; Bastian M; Ganter M
Viruses; 2019 Jun; 11(6):. PubMed ID: 31181733
[TBL] [Abstract][Full Text] [Related]
51. An inactivated vaccine for the control of bluetongue virus serotype 16 infection in sheep in Italy.
Savini G; Ronchi GF; Leone A; Ciarelli A; Migliaccio P; Franchi P; Mercante MT; Pini A
Vet Microbiol; 2007 Sep; 124(1-2):140-6. PubMed ID: 17499459
[TBL] [Abstract][Full Text] [Related]
52. Assessment of efficacy of a bivalent BTV-2 and BTV-4 inactivated vaccine by vaccination and challenge in cattle.
Savini G; Hamers C; Conte A; Migliaccio P; Bonfini B; Teodori L; Di Ventura M; Hudelet P; Schumacher C; Caporale V
Vet Microbiol; 2009 Jan; 133(1-2):1-8. PubMed ID: 18617335
[TBL] [Abstract][Full Text] [Related]
53. Humoral response to 2 inactivated bluetongue virus serotype-8 vaccines in South American camelids.
Zanolari P; Bruckner L; Fricker R; Kaufmann C; Mudry M; Griot C; Meylan M
J Vet Intern Med; 2010; 24(4):956-9. PubMed ID: 20492489
[TBL] [Abstract][Full Text] [Related]
54. Immunologic response of sheep to inactivated and virulent bluetongue virus.
Stott JL; Barber TL; Osburn BI
Am J Vet Res; 1985 May; 46(5):1043-9. PubMed ID: 2988376
[TBL] [Abstract][Full Text] [Related]
55. A comparison of different vaccination schemes used in sheep combining inactivated bluetongue vaccines against serotypes 4 and 8.
Hilke J; Strobel H; Woelke S; Stoeter M; Voigt K; Grimm L; Meilwes J; Punsmann T; Blaha I; Salditt A; Rohn K; Bastian M; Ganter M
Vaccine; 2019 Sep; 37(39):5844-5853. PubMed ID: 31431410
[TBL] [Abstract][Full Text] [Related]
56. Seroconversion, neutralising antibodies and protection in bluetongue serotype 8 vaccinated sheep.
Oura CA; Wood JL; Sanders AJ; Bin-Tarif A; Henstock M; Edwards L; Floyd T; Simmons H; Batten CA
Vaccine; 2009 Dec; 27(52):7326-30. PubMed ID: 19786141
[TBL] [Abstract][Full Text] [Related]
57. Recombinant bluetongue virus with hemagglutinin epitopes in VP2 has potential as a labeled vaccine.
Guo Y; Huang L; Bi K; Xu Q; Bu Z; Wang F; Sun E
Vet Microbiol; 2020 Sep; 248():108825. PubMed ID: 32891953
[TBL] [Abstract][Full Text] [Related]
58. An experimental inactivated vaccine against bluetongue.
Parker J; Herniman KA; Gibbs EP; Sellers RF
Vet Rec; 1975 Mar; 96(13):284-7. PubMed ID: 165609
[TBL] [Abstract][Full Text] [Related]
59. Expression of the major core structural protein (VP7) of bluetongue virus, by a recombinant capripox virus, provides partial protection of sheep against a virulent heterotypic bluetongue virus challenge.
Wade-Evans AM; Romero CH; Mellor P; Takamatsu H; Anderson J; Thevasagayam J; Fleming MJ; Mertens PP; Black DN
Virology; 1996 Jun; 220(1):227-31. PubMed ID: 8659119
[TBL] [Abstract][Full Text] [Related]
60. Four-segmented Rift Valley fever virus induces sterile immunity in sheep after a single vaccination.
Wichgers Schreur PJ; Kant J; van Keulen L; Moormann RJ; Kortekaas J
Vaccine; 2015 Mar; 33(12):1459-64. PubMed ID: 25665959
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
